Rafael Holdings, Inc. RFL Income Tax Reconciliation Orphan Drug Credits
Income Tax Reconciliation Orphan Drug Credits at other companies
Other financials
Where this comes from
Reported directly by Rafael Holdings, Inc. in its filing.
Tagged under the XBRL concept rfl:IncomeTaxReconciliationOrphanDrugCredits.
The official record: Rafael Holdings, Inc.’s 10-K, filed October 29, 2025, on SEC EDGAR. View the filing →
Ask your AI about Rafael Holdings, Inc.'s income tax reconciliation orphan drug credits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rafael Holdings, Inc.'s income tax reconciliation orphan drug credits?
- Rafael Holdings, Inc. (RFL) reported income tax reconciliation orphan drug credits of -$261.25K in Q2 2025.
- What does income tax reconciliation orphan drug credits mean?
- Captures the tax credits claimed by the company for expenditures related to the development of drugs for rare diseases. This metric is a key indicator of the company's R&D focus on specialized therapeutic areas and its ability to utilize government incentives to lower its tax burden.